Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2007-10-09
2007-10-09
Meller, Michael (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Reexamination Certificate
active
10988393
ABSTRACT:
A novel formulation is provided that serves to inhibit the inflammatory response in animals. The formulation comprises, as a first component an effective amount of a curcuminoid species and an effective amount of a second component selected from the group consisting of an alpha-acid species or a beta-acid species or derivatives thereof. The composition provides synergistic anti-inflammatory effects in response to physical or chemical injury or abnormal immune stimulation due to a biological agent or unknown etiology.
REFERENCES:
patent: 3552975 (1971-01-01), Worden
patent: 3720517 (1973-03-01), Bavisotto et al.
patent: 3932603 (1976-01-01), Haas
patent: 3933919 (1976-01-01), Wilkinson
patent: 3965188 (1976-06-01), Westermann et al.
patent: 4123561 (1978-10-01), Grant
patent: 4133903 (1979-01-01), Thiele et al.
patent: 4154865 (1979-05-01), Grant
patent: 4401684 (1983-08-01), Versluys
patent: 4554170 (1985-11-01), Panzner et al.
patent: 4644084 (1987-02-01), Cowles et al.
patent: 4692280 (1987-09-01), Spinelli
patent: 4767640 (1988-08-01), Goldstein et al.
patent: 5006337 (1991-04-01), Motitschke et al.
patent: 5013571 (1991-05-01), Hay
patent: 5073396 (1991-12-01), Todd, Jr.
patent: 5082975 (1992-01-01), Todd, Jr. et al.
patent: 5155276 (1992-10-01), Paul
patent: 5166449 (1992-11-01), Todd, Jr. et al.
patent: 5286506 (1994-02-01), Millis et al.
patent: 5296637 (1994-03-01), Stegink et al.
patent: 5387425 (1995-02-01), Hsu et al.
patent: 5604263 (1997-02-01), Tobe et al.
patent: 5624236 (1997-04-01), Kubo et al.
patent: 5827895 (1998-10-01), Nutter et al.
patent: 6020019 (2000-02-01), Ting et al.
patent: 6129907 (2000-10-01), Sreenivasan et al.
patent: 6200594 (2001-03-01), Ernest et al.
patent: 6383527 (2002-05-01), Artman et al.
patent: 6391346 (2002-05-01), Newmark et al.
patent: 6583322 (2003-06-01), Shalai et al.
patent: 2002/0086062 (2002-07-01), Kuhrts
patent: 2002/0086070 (2002-07-01), Kuhrts
patent: 2004/0072900 (2004-04-01), Artman et al.
patent: 2212148 (1973-09-01), None
patent: 363211219 (1988-09-01), None
patent: 410025247 (1998-01-01), None
patent: WO 00/68356 (2000-11-01), None
patent: WO 02/02582 (2002-01-01), None
Verzele et al., Chemistry and analysis of hop and beer bitter acids, Developments in food science, 27, pp. 44-51, 88-139, 1991.
European Search Report for related European Application No.: 02784313.5.
Abstract of Database WPI Week, 1996, Derwent Publications Ltd., London.
Anto, et al., “Anti-inflammatory Activity of Natural and Synthetic Curcuminoids”, Pharmacy and Pharmacology Communications, vol. 4, No. 2, 1998, 103-106.
Chandra, et al., “Anti-inflammatory and Anti-Arthritic Activity of Volatile Oil of Curcume Longa(Haldi)”, Indian Journal of Med. Research, vol. 60, No. 1, 1972, 138-142.
Bermejo, et al. Rev. Esp. Enferm. Dig. 95: 621-624 and 625-628 (2003).
Brown, et al. J. Chem. Soc. 545 (1959).
Byrne, et al. J. Chem. Soc. (C):2810 (1971).
Carroccio, et al. Clin. Chem. 49:861-867 (2003).
Carson, J. Am. Chem. Soc. 73: 1850-1851 (1951).
Charlier, et al. Eur. J. Med. Chem. 38:645-659 (2003).
Chou, et al. Adv Enzyme Regul 22:27-55 (1984).
Chou, et al. Eur. J. Biochem. 115:207-216 (1981).
Chou, et al. J. Biol. Chem. 252:6438-6442 (1977).
Chou, et al. J. Theor. Biol. 35:285-297 (1972).
Chou, J. Theor. Biol. 59:253-276 (1976).
Chou, et al. TIPS, vol. 4, 450-454 (1983).
Costa,et al. Digest. Liver Dis. 35:642-647 (2003).
Ding, et al. Biochem. Biophy. Res. Comm. 261:218-223 (1999.
Goldstein, et al. Am. J. Gastroenterol. 96:1019-1027 (2001).
Halter, et al. Gut 49:443-453 (2001).
Hammberg, et al. J. Bio. Chem. 246:6713-6721 (1971).
Kanematsu, et al. J Bone Miner Res 12(11):1789-1796 (1997).
Lopes, Curr. Med Res Opin. 8:145-149 (1982).
Meling, et al. Scand. J. Gastroenterol. 31:339-344 (1996).
Noreen, et al. J. Nat. Prod 61:2-7 (1998).
Pairet, et al. Inflamm. Res 47, Supplement 2S93-S101 (1998).
Panglisch, Monafsschrift fuer Brauwissen Schaft, 1990, 43(1), 4-16.
Ringbom, et al. J. Nat Prod 61:1212-1215 (1998).
Pippa, et al. Scand. J. Gastroenterol. Suppl. 167:32-35 (1989).
Poullis,et al. J. Gastroenterol. Hepatol. 18:756-762 (2003).
Røseth, Digest. Liver Dis. 35:607-609 (2003).
Shah, et al. Gut 48:339-346 (2001).
Schjerven, et al. Br: J. Dermatol. 149:484-491 (2003).
Shureiqi, et al. Cancer Res. 61:6307-6312 (2001).
Sivri, Fundam. Clinic. Pharmacol. 18:23-31 (2004).
Subbaramaiah, et al. Cancer Res. 60:2399-2404 (2000).
Suh, et al. Cancer Res 58:717-723 (1988).
Newark, et al., “Beyond Aspirin”, pp. 147-150, Hohm Press (2000).
Tagashira, et al., Biosci, Biotech. Biochem. 59(4):740-742 (1996).
Tibble, et al. Drugs Today 37:85-96 (2001).
Tibble, et al. Gut 45:362-366 (1999).
Tobe, et al. Biosci. Biotech. Biochem 61(1):158-159 (1997).
Wang, et al. Free Radical Biology & Medicine 27:612-616 (1999).
Warner, et al. Proc Natl Acad Sci USA 96:7563-7568 (1999).
Yamamoto, FEBS Letters 465: 103-106 (2000).
Yui, et al. Biol. Pharm. Bull. 26:753-760 (2003).
Information on “Zyflamend and Zyflamend PM”, downloaded from Internet Aug. 30, 2002.
Information on “ArthroTrimTM product”, downloaded from Internet Aug. 30, 2002.
Germany, “The Absolutely German Drink,” contents of beer, 2004, 5 pages.
Information on “Hops and Beer Flavours”, IOB Technical Symposium, Apr. 2001, pp. 1-9.
Babish John G.
Howell Terrence M.
Pacioretty Linda M.
McDermott Will & Emery LLP
Meller Michael
Metaproteonics, LLC
LandOfFree
Curcuminoid compositions exhibiting synergistic inhibition... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Curcuminoid compositions exhibiting synergistic inhibition..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Curcuminoid compositions exhibiting synergistic inhibition... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3896026